1. Pharmacokinetics, exposure, efficacy and safety of obinutuzumab in rituximab‐refractory follicular lymphoma patients in the GADOLIN phase III study. Issue 9 (12th July 2019) Authors: Gibiansky, Ekaterina; Gibiansky, Leonid; Buchheit, Vincent; Frey, Nicolas; Brewster, Michael; Fingerle‐Rowson, Günter; Jamois, Candice Journal: British journal of clinical pharmacology Issue: Volume 85:Issue 9(2019) Page Start: 1935 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Role of obinutuzumab exposure on clinical outcome of follicular lymphoma treated with first‐line immunochemotherapy. Issue 7 (17th May 2019) Authors: Jamois, Candice; Gibiansky, Ekaterina; Gibiansky, Leonid; Buchheit, Vincent; Sahin, Denis; Cartron, Guillaume; Marcus, Robert; Hiddemann, Wolfgang; Seymour, John F.; Strefford, Jonathan C.; Hargreaves, Chantal E.; Meneses‐Lorente, Georgina; Frey, Nicolas; Fingerle‐Rowson, Günter Journal: British journal of clinical pharmacology Issue: Volume 85:Issue 7(2019) Page Start: 1495 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗